戻る

Novo Nordisk pill users continued losing weight after switching from injections

  • Novo Nordisk presented data on patients switching from injections to its once-daily pill.
  • Patients continued losing weight after moving from injections to the pill.
  • The data was presented Wednesday at a diabetes conference in Milan.

Patients who switched from Novo Nordisk's weight-loss injections to its once-daily pill continued losing weight, according to new data presented by the Danish drugmaker Wednesday at a diabetes conference in Milan. The results could help Novo Nordisk defend a rare pocket of momentum as it battles Eli Lilly.

当サイトの情報はAIを用いて生成されており、正確性を保証するものではありません。 参考情報としてご活用ください。